Company Eckert & Ziegler SE

Equities

EUZ

DE0005659700

Office Equipment

Market Closed - Xetra 11:35:23 2024-04-26 am EDT 5-day change 1st Jan Change
36.72 EUR +1.89% Intraday chart for Eckert & Ziegler SE +10.60% -11.09%

Business Summary

Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.

Number of employees: 1,075

Sales per Business

EUR in Million2022Weight2023Weight Delta
Isotope Products
53.2 %
131 59.1 % 131 53.2 % -0.36%
Medical
46.8 %
91 40.9 % 115 46.8 % +26.78%

Sales per region

EUR in Million2022Weight2023Weight Delta
Europe
39.7 %
95 42.7 % 98 39.7 % +2.74%
North America
39.3 %
79 35.4 % 97 39.3 % +22.74%
Asia Pacific
12.6 %
23 10.1 % 31 12.6 % +37.33%
Other
8.5 %
26 11.7 % 21 8.5 % -19.54%

Managers

Managers TitleAgeSince
Chief Executive Officer 57 16-12-31
Founder 55 96-12-31
Investor Relations Contact - -
Sales & Marketing - -
Corporate Officer/Principal 71 -
Corporate Officer/Principal 66 23-06-06

Members of the board

Members of the board TitleAgeSince
Director/Board Member 71 18-12-31
Founder 55 96-12-31
Director/Board Member 71 19-05-28
Director/Board Member 64 13-12-31
Director/Board Member 56 22-12-19
Director/Board Member 56 16-12-31
Corporate Officer/Principal 71 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 21,171,932 14,174,462 ( 66.95 %) 345,577 ( 1.632 %) 66.95 %

Shareholders

NameEquities%Valuation
6,589,964 31.13 % 267 M €
Union Investment Privatfonds GmbH
3.832 %
811,313 3.832 % 33 M €
Norges Bank Investment Management
3.372 %
713,860 3.372 % 29 M €
Serafin Asset Management AG
0.8722 %
184,667 0.8722 % 7 M €
Amundi Asset Management SA (Investment Management)
0.8644 %
183,000 0.8644 % 7 M €
Lupus alpha Asset Management AG
0.8407 %
178,000 0.8407 % 7 M €
Metzler Asset Management GmbH
0.7210 %
152,650 0.7210 % 6 M €
Crédit Mutuel Asset Management SA
0.6660 %
141,000 0.6660 % 6 M €
Joh. Berenberg, Gossler & Co. KG (Investment Management)
0.6308 %
133,558 0.6308 % 5 M €
FIVV Finanzinformation & Vermögensverwaltung AG
0.5517 %
116,815 0.5517 % 5 M €

Company contact information

Eckert & Ziegler Strahlen- und Medizintechnik AG

Robert-Rössle-Strasse 10

13125, Berlin

+49 30 94 10 84 0

http://www.ezag.de
address Eckert & Ziegler SE(EUZ)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Drugstore Chains

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
36.72 EUR
Average target price
60 EUR
Spread / Average Target
+63.40%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. EUZ Stock
  4. Company Eckert & Ziegler SE